Regulation and Biological Functions of the CX3CL1-CX3CR1 Axis and Its Relevance in Solid Cancer: A Mini-review

Overview

Journal J Cancer

Specialty Oncology

Date 2021 Jan 4

PMID 33391453

Citations 39

Authors

Selma Rivas-Fuentes

Alfonso Salgado-Aguayo

Jenny Arratia-Quijada

Patricia Gorocica-Rosete

Affiliations

Soon will be listed here.

Abstract

CX3CL1 is a transmembrane protein from which a soluble form can be generated by proteolytic shedding. Membranal and soluble forms of CX3CL1 exhibit different functions, although both bind to the CX3CR1 chemokine receptor. The CX3CL1-CX3CR1 axis mediates the adhesion of leukocytes and is also involved in cell survival and recruitment of immune cell subpopulations. The function of CX3CL1 is finely tuned by cytokines and transcription factors regulating its expression and post-translational modifications. On homeostasis, the CX3CL1-CX3CR1 axis participates in the removal of damaged neurons and neurogenesis, and it is also involved on several pathological contexts. The CX3CL1-CX3CR1 axis induces several cellular responses relevant to cancer such as proliferation, migration, invasion and apoptosis resistance. In this review, we address biological aspects of this molecular axis with important therapeutic potential, emphasizing its role in cancer, one of the most prevalent chronic diseases which significantly affect the quality of life and life expectancy of patients.

Citing Articles

The expression patterns of different cell types and their interactions in the tumor microenvironment are predictive of breast cancer patient response to neoadjuvant chemotherapy.

Dhruba S, Sahni S, Wang B, Wu D, Rajagopal P, Schmidt Y bioRxiv. 2024; .

PMID: 39372749 PMC: 11451622. DOI: 10.1101/2024.06.14.598770.

Pravastatin prevents colitis-associated carcinogenesis by reducing CX3CR1 M2-like fibrocyte counts in the inflamed colon.

Hachiya K, Masuya M, Kuroda N, Yoneda M, Nishimura K, Shiotani T Sci Rep. 2024; 14(1):23021.

PMID: 39362935 PMC: 11449942. DOI: 10.1038/s41598-024-74215-9.

The Role of the CX3CR1-CX3CL1 Axis in Respiratory Syncytial Virus Infection and the Triggered Immune Response.

Rivas-Fuentes S, Salgado-Aguayo A, Santos-Mendoza T, Sevilla-Reyes E Int J Mol Sci. 2024; 25(18).

PMID: 39337288 PMC: 11432029. DOI: 10.3390/ijms25189800.

Identification of significant biomarkers for predicting the risk of bipolar disorder with arteriosclerosis based on integrative bioinformatics and machine learning.

Zheng X, Zhang X, Zhang Y, Chen C, Ji E Front Psychiatry. 2024; 15:1392437.

PMID: 39290304 PMC: 11405317. DOI: 10.3389/fpsyt.2024.1392437.

Aging Microglia and Their Impact in the Nervous System.

von Bernhardi R, Eugenin J Adv Neurobiol. 2024; 37:379-395.

PMID: 39207703 DOI: 10.1007/978-3-031-55529-9_21.

References

Yang C, Deng Y, Tang J, Cheng S, Chen S, Li Y . MicroRNA-29b regulates migration in oral squamous cell carcinoma and its clinical significance. Oral Oncol. 2014; 51(2):170-7. DOI: 10.1016/j.oraloncology.2014.10.017. View

Metzemaekers M, Van Damme J, Mortier A, Proost P . Regulation of Chemokine Activity - A Focus on the Role of Dipeptidyl Peptidase IV/CD26. Front Immunol. 2016; 7:483. PMC: 5104965. DOI: 10.3389/fimmu.2016.00483. View

Homey B, Muller A, Zlotnik A . Chemokines: agents for the immunotherapy of cancer?. Nat Rev Immunol. 2002; 2(3):175-84. DOI: 10.1038/nri748. View

Ren H, Zhao T, Sun J, Wang X, Liu J, Gao S . The CX3CL1/CX3CR1 reprograms glucose metabolism through HIF-1 pathway in pancreatic adenocarcinoma. J Cell Biochem. 2013; 114(11):2603-11. DOI: 10.1002/jcb.24608. View

Volin M, Huynh N, Klosowska K, Chong K, Woods J . Fractalkine is a novel chemoattractant for rheumatoid arthritis fibroblast-like synoviocyte signaling through MAP kinases and Akt. Arthritis Rheum. 2007; 56(8):2512-22. DOI: 10.1002/art.22806. View

Guo C, Buranych A, Sarkar D, Fisher P, Wang X . The role of tumor-associated macrophages in tumor vascularization. Vasc Cell. 2013; 5(1):20. PMC: 3913793. DOI: 10.1186/2045-824X-5-20. View

Wada A, Ito A, Iitsuka H, Tsuneyama K, Miyazono T, Murakami J . Role of chemokine CX3CL1 in progression of multiple myeloma via CX3CR1 in bone microenvironments. Oncol Rep. 2015; 33(6):2935-9. DOI: 10.3892/or.2015.3941. View

Wang H, Cai J, Du S, Guo Z, Xin B, Wang J . Fractalkine/CX3CR1 induces apoptosis resistance and proliferation through the activation of the AKT/NF-κB cascade in pancreatic cancer cells. Cell Biochem Funct. 2017; 35(6):315-326. DOI: 10.1002/cbf.3278. View

Marchica V, Toscani D, Corcione A, Bolzoni M, Storti P, Vescovini R . Bone Marrow CX3CL1/Fractalkine is a New Player of the Pro-Angiogenic Microenvironment in Multiple Myeloma Patients. Cancers (Basel). 2019; 11(3). PMC: 6469019. DOI: 10.3390/cancers11030321. View

10.

Bacon K, Baggiolini M, Broxmeyer H, Horuk R, Lindley I, Mantovani A . Chemokine/chemokine receptor nomenclature. J Interferon Cytokine Res. 2002; 22(10):1067-8. DOI: 10.1089/107999002760624305. View

11.

Chandrasekar B, Mummidi S, Perla R, Bysani S, Dulin N, Liu F . Fractalkine (CX3CL1) stimulated by nuclear factor kappaB (NF-kappaB)-dependent inflammatory signals induces aortic smooth muscle cell proliferation through an autocrine pathway. Biochem J. 2003; 373(Pt 2):547-58. PMC: 1223517. DOI: 10.1042/BJ20030207. View

12.

Park M, Lee J, Yoon J . High expression of CX3CL1 by tumor cells correlates with a good prognosis and increased tumor-infiltrating CD8+ T cells, natural killer cells, and dendritic cells in breast carcinoma. J Surg Oncol. 2012; 106(4):386-92. DOI: 10.1002/jso.23095. View

13.

Wang J, Gan Y, Han P, Yin J, Liu Q, Ghanian S . Ischemia-induced Neuronal Cell Death Is Mediated by Chemokine Receptor CX3CR1. Sci Rep. 2018; 8(1):556. PMC: 5765008. DOI: 10.1038/s41598-017-18774-0. View

14.

Huang L, Ma B, Ma J, Wang F . Fractalkine/CX3CR1 axis modulated the development of pancreatic ductal adenocarcinoma via JAK/STAT signaling pathway. Biochem Biophys Res Commun. 2017; 493(4):1510-1517. DOI: 10.1016/j.bbrc.2017.10.006. View

15.

Clark A, Yip P, Malcangio M . The liberation of fractalkine in the dorsal horn requires microglial cathepsin S. J Neurosci. 2009; 29(21):6945-54. PMC: 2698289. DOI: 10.1523/JNEUROSCI.0828-09.2009. View

16.

Meucci O, Fatatis A, Simen A, Miller R . Expression of CX3CR1 chemokine receptors on neurons and their role in neuronal survival. Proc Natl Acad Sci U S A. 2000; 97(14):8075-80. PMC: 16672. DOI: 10.1073/pnas.090017497. View

17.

Kehlen A, Haegele M, Bohme L, Cynis H, Hoffmann T, Demuth H . N-terminal pyroglutamate formation in CX3CL1 is essential for its full biologic activity. Biosci Rep. 2017; 37(4). PMC: 5634468. DOI: 10.1042/BSR20170712. View

18.

Daoudi M, Lavergne E, Garin A, Tarantino N, Debre P, Pincet F . Enhanced adhesive capacities of the naturally occurring Ile249-Met280 variant of the chemokine receptor CX3CR1. J Biol Chem. 2004; 279(19):19649-57. DOI: 10.1074/jbc.M313457200. View

19.

Bazan J, Bacon K, Hardiman G, Wang W, Soo K, Rossi D . A new class of membrane-bound chemokine with a CX3C motif. Nature. 1997; 385(6617):640-4. DOI: 10.1038/385640a0. View

20.

Kee J, Arita Y, Shinohara K, Ohashi Y, Sakurai H, Saiki I . Antitumor immune activity by chemokine CX3CL1 in an orthotopic implantation of lung cancer model . Mol Clin Oncol. 2014; 1(1):35-40. PMC: 3956245. DOI: 10.3892/mco.2012.30. View